Incognito standardized patients for studying healthcare stigma: partial deception and other ethical challenges
Siyan Meng, Yunqing Fei, Danyang Luo, Sean Y. Sylvia, M. Kumi Smith
TL;DR
This paper explores the ethics of using hidden actors to study healthcare stigma and the challenges it raises.
Contribution
The paper introduces a new method using incognito standardized patients to study enacted stigma in healthcare.
Findings
The incognito method allows for observing real-time stigma in healthcare settings.
The approach raises ethical concerns due to partial deception and potential harm.
Balancing research benefits with ethical risks is a key challenge.
Abstract
This paper examines the ethical considerations of using the incognito clinic visits by standardized patients (SP) in order to measure enacted stigma in healthcare settings. It reviews traditional SP methods, introduces the new method, and discusses its potential harms and benefits.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMental Health Treatment and Access · Patient-Provider Communication in Healthcare · Healthcare Decision-Making and Restraints